Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Calcitriol is a vitamin D3 receptor agonist and active metabolite of vitamin D3 (Item No. 11792).1,2 It is formed via a multi-step process, in which vitamin D3 undergoes hydroxylation to 25-hydroxy vitamin D3 (Item No. 9000683) in the liver, followed by further hydroxylation at the 1α-position in the kidney. Calcitriol binds to the vitamin D3 receptor (Kd = 16 pM) and induces differentiation of U937 acute monocytic leukemia cells (EC50 = 2,000 pM).3 It induces cell cycle arrest at the S phase and apoptosis in primary adenomatous and hyperplastic human parathyroid cells when used at a concentration of 10 nM.4 Calcitriol (0.65 nmol/animal) increases bone calcium mobilization in chicks on a low calcium diet.2 It stimulates calcium absorption in the intestines in a chick model of rickets induced by a vitamin D3-deficient diet when administered at a dose of 25 µg/animal.1 Formulations containing calcitriol have been used in the treatment of hypocalcemia.
WARNING This product is not for human or veterinary use.
1. Identification of 1,25-
2. Biological activity of 1α-
3. 20-
4. The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis. J. Am. Soc. Nephrol. 11(10), 1865-1872 (2000).
The AhR agonist VAF347 augments retinoic acid-
Osteogenic and osteoclastogenic differentiation of co-